Resources
Menu
Close
Resources
Contact us
Oral solid dose
Sterile injectables
Antibody-drug conjugates
Tech transfer
OSD manufacturing
SI manufacturing
ADC manufacturing
Careers
Leadership team
Regulatory support
Sustainability
IP protection
Expert insights
SI manufacturing
Sterile injectables manufacturing infused with elite experience
As a leading global CMO with an uncompromising commitment to quality, flexibility and transparency, we elevate your sterile injectable with precision and experience.
At the forefront of complex therapeutics, we leverage Pfizer expertise to quickly adapt to your sterile injectable challenges for a swift and successful manufacturing journey.
Download brochure
Our sterile injectable manufacturing capabilities at a glance
Compounds
Services and processes
Flexible and transparent support you can rely on
Global supply chain services
We maintain an unwavering commitment to secure and dependable supply lines, safeguarding the delivery of your vital sterile injectable therapies to the patients waiting.
Primary and secondary packaging solutions
We provide flexible packaging options, accommodating a wide range of vial sizes, along with serialization and traceability. Our services encompass both bulk and final packaging.
Container closure systems
Glass vials: 2mL – 100mL
Syringes (pre-filled syringes): 1mL – 5mL (tub configuration)
Ampoules: 2mL – 10mL
Cartridges
Secondary packaging
Bulk (bright stock)
Single-/multi-unit cartons
Kitting
Explore our global OSD manufacturing network
Algete, Spain
60+ years of sterile injectable manufacturing experience
42-acre campus with 25,000 sq.ft of manufacturing space with a $100M filling line designed to reduce interventions
Integrated isolator technology within the filling line for enhanced sterility
Robust cold chain qualification, handling and distribution capabilities
Discover Algete
1/5
McPherson, USA
1.4 million sq.ft of manufacturing space and 24/7 operations
190+ million units of capacity, supplying 100+ countries
30+ years of experience and a team of 1,800+ highly skilled experts
Advanced aseptic filling with isolator and RABS technology, alongside biologics and biosimilar fill-finish capabilities
On-site analytical and microbiological expertise in method development, stability testing and controlled drug handling
Discover McPherson
2/5
Puurs, Belgium
60+ years in sterile injectable manufacturing and 400+ million doses of annual production capacity
Aseptic liquid filling: Glass ampoules, disposables, dual chamber vials and pre-filled syringes
Sterile filtration, internal/external siliconization of cartridges and lyophilization
High-volume and flexible packaging solutions
Manufacturing controlled drugs, substances, diluents and highly active compounds
Discover Puurs
3/5
Strängnäs, Sweden
70+ years of manufacturing experience in vaccines and growth hormones
95,300 sq.ft facility supported by 370+ Pfizer experts
Microbial fermentation with seed and main fermenter tanks, advanced harvest and purification technologies
Analysis (HPLC, spectrophotometry), formulation and storage (-20 to -80°C and freeze-drying) capabilities
Expertise in tech transfer, microbial drug substances handling and vaccine intermediates.
Discover Strängnäs
4/5
Zagreb, Croatia
13+ years of experience manufacturing biologics drug substance and drug product11-acre campus, ~ 479,160 square feet of manufacturing space
Microbial drug substance production
Expertise in technical transfers
Packaging products into vials and prefilled syringes
Approved site for packaging of biosimilars and small molecules, cold chain handling and warehousing
Discover Strängnäs
5/5
Lyophilization is challenging. We've been proudly doing it for over four decades.
There are many complexities facing lyophilized product manufacturing. Using our extensive experience, we can optimize and scale up your lyophilization process to match the needs of your unique compound at commercial scale.
By carefully considering your drug’s formulation and attributes, our team of experts helps to ensure proper cycle design every time.
Learn more
Expert content
WEBINAR
Technology transfer with sterile injectables
Access webinar
View all
WHITEPAPER
Considerations for migrating a drug product presentation from a vial to pre-filled syringe
Download whitepaper
View all
ARTICLE
Identifying ways to achieve a more resilient Sterile injectable supply chain
Read the article
View all
Success
Thank you, your submission has been received!
Latest marketing updates
Let’s stay in touch
Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please tick the box below.
BY TICKING THE BOX AND CLICKING “LET’S COLLABORATE” BELOW, I CONSENT TO RECEIVING THOUGHT LEADERSHIP, INDUSTRY NEWS, AND INVITATIONS BY EMAIL OR OTHER ELECTRONIC MEANS, WHICH PFIZER CENTREONE BELIEVES MAY BE OF VALUE TO ME, RELEVANT TO MY WORK AND TAILORED TO MY PROFESSIONAL PROFILE AND INTERESTS. THIS MAY INCLUDE PROMOTIONAL INFORMATION ON PRODUCTS, SERVICES AND EVENTS PROVIDED OR ORGANIZED BY PFIZER CENTREONE.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Let's Collaborate
A CMO for therapies that define legacies
Follow us
Latest marketing updates
Sign up
© 2025 Pfizer Inc. All rights reserved. Pfizer CentreOne is a registered trademark of Pfizer Inc. Privacy Policy | Terms of Use